Peripheral washout phenomenon in an animal tumour model: Comparison of dynamic magnetic resonance imaging using a small molecular contrast medium with histology

Veterinary and Comparative Oncology

Volumn 6, Issue 3, 2008, Pages 151-161

  Drees, R ^a   Hunigen H ^b   Wagner, S ^c   Schnorr, S ^c   Plendl, J ^b   Taupitz, M ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Colon carcinoma CC531; Contrast medium; DCE MRI; Peripheral washout; Small molecular; Tumour

Indexed keywords

ANIMALIA; RATTUS;

CONTRAST MEDIUM;

ANIMAL; ARTICLE; EXPERIMENTAL NEOPLASM; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RAT; RAT STRAIN; SENSITIVITY AND SPECIFICITY; SKIN TUMOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED STRAINS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 63849095858     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2007.00156.x     Document Type: Article

References (34)

1. Barrett T, Kobayashi H, Brechbiel M and Choyke PL. Macromolecular MRI contrast agents for imaging tumor angiogenesis. European Journal of Radiology 2006; 60: 353-366.
2. Kuszyk BS, Corl FM, Franano FN, Bluemke DA, Hofmann LV, Fortman BJ and Fishman EK. Tumor transport physiology: Implications for imaging and imaging-guided therapy. AJR American Journal of Roentgenology 2001; 177: 747-753.
3. Burns PN and Wilson SR. Focal liver masses: Enhancement patterns on contrast-enhanced images - concordance of US scans with CT scans and MR images. Radiology 2007; 242: 162-174.
4. Hamm B, Thoeni RF, Gould RG, Bernardino ME, Luning M, Saini S, Manfouz AE, Taupitz M and Wolf KJ. Focal liver lesions: Characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994; 190: 417-423.
5. van Rijswijk CS, Geirnaerdt MJ, Hogendoorn PC, Taminiau AH, van Coevorden F, Zwinderman AH, Pope TL and Bloem JL. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology 2004; 233: 493-502.
6. Sherif H, Mahfouz AE, Oellinger H, Hadijuana J, Blohmer JU, Taupitz M, Felix R and Hamm B. Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 1997; 205: 209-213.
7. Mahfouz AE, Hamm B and Wolf KJ. Peripheral washout: A sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994; 190: 49-52.
8. Brasch R and Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: Status report. European Journal of Radiology 2000; 34: 148-155.
9. Turetschek K, Huber S, Floyd E, Helbich T, Roberts TP, Shames DM, Tarlo KS, Wendland MF and Brasch RC. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 2001; 218: 562-569.
10. Turetschek K, Floyd E, Shames DM, Roberts TP, Preda A, Novikov V, Corot C, Carter WO and Brasch RC. Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology. Magnetic Resonance in Medicine 2001; 45: 880-886.
11. Turetschek K, Roberts TP, Floyd E, Preda A, Novikov V, Shames DM, Carter WO and Brasch RC. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model. Journal of Magnetic Resonance Imaging 2001; 13: 882-888.
12. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y and Brasch RC. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media. AJR American Journal of Roentgenology 1998; 171: 941-949.
13. Turetschek K, Floyd E, Helbich T, Roberts TP, Shames DM, Wendland MF, Carter WO and Brasch RC. MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology. Journal of Magnetic Resonance Imaging 2001; 14: 237-242.
14. Kanellis J, Levidiotis V, Khong T, Cox AJ, Stacker SA, Gilbert RE, Cooper ME and Power DA. A study of VEGF and its receptors in two rat models of proteinuria. Nephron Physiology 2004; 96: P26-P36.
15. Itai Y, Ohtomo K, Kokubo T, Yamauchi T, Minami M, Yashiro N and Araki T. CT of hepatic masses: Significance of prolonged and delayed enhancement. AJR American Journal of Roentgenology 1986; 146: 729-733.
16. Muramatsu Y, Takayasu K, Moriyama N, Shima Y, Goto H, Ushio K, Yamada T, Hasegawa H, Koyama Y and Hirohashi S. Peripheral low-density area of hepatic tumors: CT-pathologic correlation. Radiology 1986; 160: 49-52.
17. Ba-Ssalamah A, Happel B, Kettenbach J, Dirisamer A, Wrba F, Längle F and Schima W. [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents]. Radiologe 2004; 44: 1170-1184.
18. Bilgili Y, Fýrat Z, Pamuklar E, Ünal B, Hyslop W, Rivero H and Semelka C. Focal liver lesions evaluated by MR imaging. Diagnostic and Interventional Radiology 2006; 12: 129-135.
19. Chen Z, Ma CM, Paskalev K, Li J, Yang J, Richardson T, Palacio L, Xu X and Chen L. Investigation of MR image distortion for radiotherapy treatment planning of prostate cancer. Physics in Medicine and Biology 2006; 51: 1393-1403.
20. Numminen K, Isoniemi H, Halavaara J, Tervahartiala P, Makisalo H, Laasonen L and Höckerstedt K. Preoperative assessment of focal liver lesions: Multidetector computed tomography challenges magnetic resonance imaging. Acta Radiologica 2005; 46: 9-15.
21. Mahfouz AE, Hamm B and Taupitz M. Contrast agents for MR imaging of the liver: A clinical overview. European Radiology 1997; 7: 507-513.
22. Jackson A. Analysis of dynamic contrast enhanced MRI. British Journal of Radiology 2004; 77: S154-S166.
23. Byrne AM, Bouchier-Hayes DJ and Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). Journal of Cellular and Molecular Medicine 2005; 9: 777-794.
24. Dvorak HF, Brown LF, Detmar M and Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology 1995; 146: 1029-1039.
25. Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD and West CM. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. British Journal of Cancer 2000; 83: 620-625.
26. Baxter LT and Jain RK. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvascular Research 1989; 37: 77-104.
27. Less JR, Posner MC, Boucher Y, Borochovitz D, Wolmark N and Jain RK. Interstitial hypertension in human breast and colorectal tumors. Cancer Research 1992; 52: 6371-6374.
28. Boucher Y, Baxter LT and Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: Implications for therapy. Cancer Research 1990; 50: 4478-4484.
29. Gutmann R, Leunig A, Leunig M and Feyh J. [Importance of increased interstitial fluid pressure in therapy of malignant tumors of the head-neck area]. Laryngorhinootologie 1993; 72: 338-341.
30. Gutmann R, Leunig M, Feyh J, Goetz AE, Messmer K, Kastenbauer E and Jair RK. Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Research 1992; 52: 1993-1995.
31. Milosevic M, Fyles A, Hedley D and Hill R. The human tumor microenvironment: Invasive (needle) measurement of oxygen and interstitial fluid pressure. Seminars in Radiation Oncology 2004; 14: 249-258.
32. Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, Manchul L and Hill R. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Research 2001; 61: 6400-6405.
33. Leunig M, Goetz AE, Dellian M, Zetterer G, Gamarra F, Jain RK and Messmer K. Interstitial fluid pressure in solid tumors following hyperthermia: Possible correlation with therapeutic response. Cancer Research 1992; 52: 487-490.
34. Milosevic M, Fyles A and Hill R. Interstitial fluid pressure in cervical cancer: Guide to targeted therapy. American Journal of Clinical Oncology 2001; 24: 516-521.